Lilly (Eli)

LLY · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

1.030%

12M weight contribution

-0.168 pp

3M weight contribution

-0.084 pp

12M price return

+46.4%

Share of matched S&P 500 members

Monthly observations through Jun 2023

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Jun 2023	$445.2bn	1.030%	-0.168 pp	+46.4%	No
May 2023	$407.7bn	1.007%	-0.065 pp	+38.7%	No
Apr 2023	$375.8bn	1.269%	+0.266 pp	+37.2%	Yes
Mar 2023	$326.4bn	1.113%	+0.196 pp	+21.4%	No
Feb 2023	$295.8bn	1.040%	+0.214 pp	+26.1%	No
Jan 2023	$327.0bn	1.119%	+0.330 pp	+42.2%	No
Dec 2022	$347.6bn	1.254%	+0.408 pp	+34.3%	Yes
Nov 2022	$352.6bn	1.197%	+0.395 pp	+51.6%	Yes
Oct 2022	$344.0bn	1.221%	+0.407 pp	+44.1%	Yes
Sep 2022	$307.2bn	1.207%	+0.431 pp	+41.9%	Yes
Aug 2022	$286.2bn	1.024%	+0.198 pp	+18.3%	No
Jul 2022	$313.3bn	1.077%	+0.276 pp	+37.3%	Yes
Jun 2022	$308.1bn	1.198%	+0.421 pp	+43.3%	Yes
May 2022	$297.8bn	1.073%	+0.386 pp	+59.1%	Yes
Apr 2022	$277.6bn	1.004%	+0.368 pp	+62.3%	Yes
Mar 2022	$272.7bn	0.918%	+0.568 pp	+55.6%	Yes
Feb 2022	$238.0bn	0.826%	+0.433 pp	+23.8%	Yes
Jan 2022	$234.7bn	0.789%	+0.313 pp	+19.8%	No
Dec 2021	$264.2bn	0.846%	+0.193 pp	+66.1%	Yes
Nov 2021	$237.3bn	0.802%	+0.210 pp	+72.9%	Yes
Oct 2021	$243.7bn	0.814%	+0.223 pp	+98.6%	Yes
Sep 2021	$221.0bn	0.776%	+0.775 pp	+58.8%	Yes
Aug 2021	$247.1bn	0.826%	+0.825 pp	+77.0%	Yes
Jul 2021	$233.5bn	0.801%	+0.800 pp	+65.1%	Yes

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.